FDA Off-Label Regs Face Cave-In Risk After Supreme Court Data-Mining Ruling
Executive Summary
Lawyers have pored over the Supreme Court's decision overturning Vermont's prescriber data mining law to see how it may be applied to other forms of pharmaceutical marketing.